...
首页> 外文期刊>World Journal of Gastroenterology >Identification of deregulated miRNAs and their targets in hepatitis B virus-associated hepatocellular carcinoma
【24h】

Identification of deregulated miRNAs and their targets in hepatitis B virus-associated hepatocellular carcinoma

机译:乙肝病毒相关肝细胞癌中miRNA及其靶标的鉴定

获取原文
   

获取外文期刊封面封底 >>

       

摘要

AIM: To identify the differentially expressed miRNAs and their targets in hepatitis B virus (HBV)-associated hepatocellular carcinoma (HCC). METHODS: Six hundred and sixty seven human miRNAs were quantitatively analyzed by Taqman low-density miRNA array (TLDA) in HBV-HCC tissues. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were used to analyze the significant function and pathway of the differentially expressed miRNAs in HBV-HCC. TargetScan software was used to predict the targets of deregulated miRNAs. Western blotting and luciferase assay were performed to verify the targets of these miRNAs. RESULTS: Ten up-regulated miRNAs (miR-217, miR-518b, miR-517c, miR-520g, miR-519a, miR-522, miR-518e, miR-525-3p, miR-512-3p, and miR-518a-3p) and 11 down-regulated miRNAs (miR-138, miR-214, miR-214#, miR-199a-5p, miR-433, miR-511, miR-592, miR-483-3p, miR-483-5p, miR-708 and miR-1275) were identified by Taqman miRNAs array and confirmed quantitatively by reverse transcription polymerase chain reaction in HCC and adjacent non-tumor tissues. GO and KEGG pathway analysis revealed that “regulation of actin cytoskeleton” and “pathway in cancer” are most likely to play critical roles in HCC tumorigenesis. MiR-519a and ribosomal protein S6 kinase polypeptide 3 (RPS6KA3) were predicted as the most significant candidates by miRNA-mRNA network. In addition, cyclin D3 (CCND3) and clathrin heavy chain (CHC), usually up-regulated in HCC tissues, were validated as the direct target of miR-138 and miR-199a-5p, respectively. CONCLUSION: Our data suggest an importance of miR-138 and miR-199a-5p as well as their targets CCND3 and CHC in HCC tumorigenesis, and may provide more evidence for reliability of integrative bioinformatics analysis.
机译:目的:鉴定在乙型肝炎病毒(HBV)相关的肝细胞癌(HCC)中差异表达的miRNA及其靶标。方法:采用Taqman低密度miRNA芯片(TLDA)对HBV-HCC组织中的667个人类miRNA进行定量分析。使用基因本体论(GO)和《京都基因与基因组百科全书》(KEGG)途径分析来分析差异表达的miRNA在HBV-HCC中的重要功能和途径。 TargetScan软件用于预测失调的miRNA的靶标。进行了蛋白质印迹和荧光素酶测定以验证这些miRNA的靶标。结果:十种上调的miRNA(miR-217,miR-518b,miR-517c,miR-520g,miR-519a,miR-522,miR-518e,miR-525-3p,miR-512-3p和miR -518a-3p)和11个下调的miRNA(miR-138,miR-214,miR-214#,miR-199a-5p,miR-433,miR-511,miR-592,miR-483-3p,miR通过Taqman miRNA阵列鉴定了-483-5p,miR-708和miR-1275),并通过逆转录聚合酶链反应在HCC和邻近非肿瘤组织中进行了定量确认。 GO和KEGG通路分析表明,“肌动蛋白细胞骨架的调节”和“癌症通路”最有可能在HCC肿瘤发生中起关键作用。 miR-mRNA网络预测MiR-519a和核糖体蛋白S6激酶多肽3(RPS6KA3)是最重要的候选基因。此外,通常在HCC组织中上调的细胞周期蛋白D3(CCND3)和网格蛋白重链(CHC)分别被证实是miR-138和miR-199a-5p的直接靶标。结论:我们的数据表明miR-138和miR-199a-5p及其靶标CCND3和CHC在HCC肿瘤发生中的重要性,并可能为整合生物信息学分析的可靠性提供更多证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号